(Q41616374)

5 October 2017

Menogaril in the treatment of malignant mesothelioma: a phase II study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1386842

21 September 2022

author name string

C. A. Hudis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1386842

21 September 2022

D. P. Kelsen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1386842

21 September 2022

language of work or name

1 reference

1 July 1992

1 reference

Investigational New Drugs

5 October 2017

1 reference

5 October 2017

10

1 reference

5 October 2017

2

1 reference

5 October 2017

103-106

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00873126

5 October 2017

0 references

cites work

Phase II trial of high-dose cisplatin in patients with malignant mesothelioma

1 reference

12 December 2020

Surgical treatment of pleural mesothelioma.

1 reference

12 December 2020

Current concepts: malignant mesothelioma

1 reference

12 December 2020

Malignant mesothelioma. The Eastern Cooperative Oncology Group (ECOG) experience

1 reference

12 December 2020

Asbestos-related diseases

1 reference

12 December 2020

Vindesine in the treatment of malignant mesothelioma: a phase II study

1 reference

12 December 2020

Malignant mesothelioma of the pleura: review of 123 patients

1 reference

12 December 2020

Multimodality therapy for malignant mesothelioma based on a study of natural history

1 reference

12 December 2020

Chronic cardiotoxicity studies in rabbits with 7-con-O-methylnogarol, a new anthracycline antitumor agent

1 reference

12 December 2020

Phase I study of intravenous menogaril administered intermittently

1 reference

12 December 2020

Chemotherapy in the treatment of malignant mesothelioma

1 reference

12 December 2020

Therapeutic approaches in malignant mesothelioma

1 reference

12 December 2020

Intracellular uptake of 7-con-o-methylnogarol and adriamycin by cells in culture and its relationship to cell survival

1 reference

12 December 2020

Diffuse malignant mesothelioma. Prospective evaluation of 69 patients

1 reference

12 December 2020

Phase II trial of mitomycin in malignant mesothelioma

1 reference

12 December 2020

Lethality of nogalamycin, nogalamycin analogs, and adriamycin to cells in different cell cycle phases

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00873126

1 reference

Dimensions Publication ID

5 October 2017

0 references

1 reference